Certain strategies for treating or preventing intracerebral hemorrhages (ICHs), also known as bleeding strokes, may not be as effective as physicians previously believed, according to a new guidance document from the…

Improved shielding can lead help limit radiation exposure among endovascular aortic repair (EVAR) operators, according to a new analysis published in the European Journal of Vascular & Endovascular Surgery.[1]…

A team of cardiologists and surgeons at Hackensack University Medical Center in New Jersey believe they have made history by…

Carotid endarterectomy (CEA) is not associated with a significant reduction in the risk of dementia, according to a new analysis…

It has been a busy few weeks for the U.S. Food and Drug Administration (FDA). The agency…

Introducing hospitals to different decision support tools (DSTs) can improve the level of shared decision-making (SDM) among vascular surgeons and their patients, according to a new study published in the European Journal of…

Acknowledging the complexity and multifaceted nature of caring for patients with chronic limb-threatening ischemia (CLTI), eight medical societies cooperated to develop and release a …

The U.S. Preventive Services Task Force (USPSTF) has published its final recommendation statement on the practice of taking daily low-dose aspirin to prevent…

Transit Scientific, a Salt Lake City-based healthcare technology company, has received U.S. FDA clearance for its XO Cross Support Catheter Platform, already approved for peripheral vascular…

A history of allergic disorders — including asthma, digestive allergies and skin allergies — is associated with a heightened risk of high blood pressure and/or coronary heart disease, according to a new analysis of more than 34,000…

Mortality rates from myocardial infarction (MI), stroke and pulmonary embolism (PE) improved from 1998 to 2015 among patients receiving dialysis, according to new findings published in JAMA Network Open.[1] In fact, mortality…

FundamentalVR, a London-based healthcare technology company that designs virtual reality (VR) solutions, has announced that it will now be offering haptic training simulations focused on…

When treating patients at a high bleeding risk (HBR) with percutaneous coronary intervention (PCI), the use of a drug-coated balloon (DCB) appears to be as safe and effective as a current-generation drug-eluting stent (DES), according…

Certain low-risk ST-segment elevation myocardial infarction (STEMI) patients can undergo percutaneous coronary intervention (PCI) without stenting, according to new findings published in EuroIntervention.[1]…

Artrya Limited, an Australian healthcare technology company focused on diagnosing coronary artery disease (CAD), has expanded its operations to the United States.

…

COVID-19 patients face a heightened risk of deep vein thrombosis (DVT) for up to three months after their infection, according to a new analysis of more than five million patients published in The BMJ.[1] Researchers also…

ACC.22, the American College of Cardiology’s 71st Annual Scientific Session and Expo, saved some of its biggest late-breaking clinical trials for its final day.

Monday morning’s late-breakers began…

ACC.22, the American College of Cardiology’s 71st Annual Scientific Session & Expo, is underway in Washington, D.C., giving many cardiology professionals their first taste of an in-person conference since the start of the COVID-19…

Patients battling depression after a heart attack may be much more likely to suffer a stroke, according to new research presented at ACC.22, the American College of Cardiology’s 71st Annual Scientific Session.

…

Medtronic has recalled approximately 6,000 IN.PACT Admiral catheters and three IN.PACT AV catheters, the company announced Thursday.

This is a voluntary recall due to potential pouch damage that…